Targeting STING pathways for the treatment of cancer

Claudia Gravekamp, Dinesh Chandra

Research output: Contribution to journal › Article

6 Citations (Scopus)

Abstract

Recently, we demonstrated that stimulator of interferon genes (STING) ligand cyclic di-guanylate (c-di-GMP) is an excellent adjuvant in cancer vaccination but also induces immunogenic tumor cell death. Combination of both pathways resulted in a nearly complete elimination of the metastases in a breast cancer model. This study is discussed below.

Original languageEnglish (US)
JournalOncoImmunology
Volume4
Issue number12
DOIs
StatePublished - Dec 2 2015

Fingerprint

Interferons
Genes
Neoplasms
Vaccination
Cell Death
Breast Neoplasms
Neoplasm Metastasis
Ligands
Therapeutics
bis(3',5')-cyclic diguanylic acid

Keywords

  • c-di-GMP
  • IL-12
  • Listeria-Mage-b
  • metastatic breast cancer
  • STING ligand

ASJC Scopus subject areas

  • Immunology and Allergy
  • Oncology
  • Immunology

Cite this

Targeting STING pathways for the treatment of cancer. / Gravekamp, Claudia; Chandra, Dinesh.

In: OncoImmunology, Vol. 4, No. 12, 02.12.2015.

Research output: Contribution to journal › Article

Gravekamp, C & Chandra, D 2015, 'Targeting STING pathways for the treatment of cancer', OncoImmunology, vol. 4, no. 12. https://doi.org/10.4161/2162402X.2014.988463
Gravekamp C, Chandra D. Targeting STING pathways for the treatment of cancer. OncoImmunology. 2015 Dec 2;4(12). https://doi.org/10.4161/2162402X.2014.988463
Gravekamp, Claudia ; Chandra, Dinesh. / Targeting STING pathways for the treatment of cancer. In: OncoImmunology. 2015 ; Vol. 4, No. 12.
@article{433a06befaa043c8b7a9b74b10cbc7d5,
title = "Targeting STING pathways for the treatment of cancer",
abstract = "Recently, we demonstrated that stimulator of interferon genes (STING) ligand cyclic di-guanylate (c-di-GMP) is an excellent adjuvant in cancer vaccination but also induces immunogenic tumor cell death. Combination of both pathways resulted in a nearly complete elimination of the metastases in a breast cancer model. This study is discussed below.",
keywords = "c-di-GMP, IL-12, Listeria-Mage-b, metastatic breast cancer, STING ligand",
author = "Claudia Gravekamp and Dinesh Chandra",
year = "2015",
month = "12",
day = "2",
doi = "10.4161/2162402X.2014.988463",
language = "English (US)",
volume = "4",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "Landes Bioscience",
number = "12",

}

TY - JOUR

T1 - Targeting STING pathways for the treatment of cancer

AU - Gravekamp, Claudia

AU - Chandra, Dinesh

PY - 2015/12/2

Y1 - 2015/12/2

N2 - Recently, we demonstrated that stimulator of interferon genes (STING) ligand cyclic di-guanylate (c-di-GMP) is an excellent adjuvant in cancer vaccination but also induces immunogenic tumor cell death. Combination of both pathways resulted in a nearly complete elimination of the metastases in a breast cancer model. This study is discussed below.

AB - Recently, we demonstrated that stimulator of interferon genes (STING) ligand cyclic di-guanylate (c-di-GMP) is an excellent adjuvant in cancer vaccination but also induces immunogenic tumor cell death. Combination of both pathways resulted in a nearly complete elimination of the metastases in a breast cancer model. This study is discussed below.

KW - c-di-GMP

KW - IL-12

KW - Listeria-Mage-b

KW - metastatic breast cancer

KW - STING ligand

UR - http://www.scopus.com/inward/record.url?scp=84944522894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944522894&partnerID=8YFLogxK

U2 - 10.4161/2162402X.2014.988463

DO - 10.4161/2162402X.2014.988463

M3 - Article

VL - 4

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 12

ER -

Access to Document